Skip to main content
OpenTrials

Clinical trial condition

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

Explore clinical trials studying Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity. Study availability and eligibility vary by location and protocol.

28 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity trial results

Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Suburban Hospital Bethesda, Maryland, United States
View Trial Details

Related conditions